ClinicalTrials.gov
public full text
Public Domain
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
fatty-liverliver-diseasemashmasldmetabolic-diseasesnonalcoholic-fatty-liver-diseasenonalcoholic-steatohepatitis
The study will assess the efficacy and safety of pegozafermin administered in participants with compensated cirrhosis due to MASH (biopsy-confirmed fibrosis stage F4 MASH \[previously known as nonalcoholic steatohepatitis, NASH\]).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH#878958
- Pharmacological treatment of MASH#1148616
- Screening for MASLD-related Advanced Fibrosis in Type 2 Diabetes#834735
- Study of TGM-312-SC01 in Healthy Participants and Adults With MASH#1096426
- CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)#847926
Record · ID 888266
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive